Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Dopamine D2 receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin 2 (5-HT2) receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | carbon monoxyde dehydrogenase large chain CoxL | 0.0053 | 0.1007 | 0.2238 |
Echinococcus multilocularis | acetylcholinesterase | 0.022 | 1 | 1 |
Onchocerca volvulus | 0.0037 | 0.0175 | 0.5 | |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0037 | 0.0175 | 0.0651 |
Echinococcus multilocularis | acetylcholinesterase | 0.022 | 1 | 1 |
Mycobacterium tuberculosis | Probable carbon monoxyde dehydrogenase (large chain) | 0.0084 | 0.2679 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.022 | 1 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.022 | 1 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.022 | 1 | 1 |
Onchocerca volvulus | 0.0037 | 0.0175 | 0.5 | |
Mycobacterium ulcerans | carbon monoxide dehydrogenase | 0.0118 | 0.4502 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.022 | 1 | 1 |
Onchocerca volvulus | 0.0037 | 0.0175 | 0.5 | |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase large chain CoxL | 0.0084 | 0.2679 | 0.5951 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase medium chain CoxM | 0.006 | 0.1401 | 0.3111 |
Mycobacterium ulcerans | aerobic-type carbon monoxide dehydrogenase subunit CoxM_2 | 0.006 | 0.1401 | 0.3111 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.022 | 1 | 1 |
Onchocerca volvulus | 0.0037 | 0.0175 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.022 | 1 | 1 |
Trichomonas vaginalis | xanthine dehydrogenase, putative | 0.0177 | 0.7726 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.022 | 1 | 1 |
Echinococcus granulosus | carboxylesterase 5A | 0.022 | 1 | 1 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0037 | 0.0175 | 0.0651 |
Mycobacterium tuberculosis | Probable carbon monoxyde dehydrogenase (medium chain) | 0.006 | 0.1401 | 0.5229 |
Mycobacterium ulcerans | aerobic-type carbon monoxide dehydrogenase subunit CoxL_2 | 0.0084 | 0.2679 | 0.5951 |
Trichomonas vaginalis | xanthine dehydrogenase, putative | 0.0177 | 0.7726 | 1 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0037 | 0.0175 | 0.0651 |
Echinococcus multilocularis | carboxylesterase 5A | 0.022 | 1 | 1 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0037 | 0.0175 | 0.0388 |
Trichomonas vaginalis | aldehyde oxidase, putative | 0.0177 | 0.7726 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.022 | 1 | 1 |
Onchocerca volvulus | 0.0037 | 0.0175 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 0.16 mg kg-1 | Ability to inhibit apomorphine-induced climbing behavior in mice. | ChEMBL. | 7707315 |
ED50 (functional) | = 0.16 mg kg-1 | Ability to inhibit apomorphine-induced climbing behavior in mice. | ChEMBL. | 7707315 |
ED50 (functional) | = 13 mg kg-1 | Ability to block apomorphine-induced stereotypy in rats. | ChEMBL. | 7707315 |
IC50 (binding) | = 2 nM | Affinity for 5-hydroxytryptamine 2 receptor binding sites by its ability to displace [3H]-spiperone from rat frontal cortex. | ChEMBL. | 7707315 |
IC50 (binding) | = 2 nM | Affinity for 5-hydroxytryptamine 2 receptor binding sites by its ability to displace [3H]-spiperone from rat frontal cortex. | ChEMBL. | 7707315 |
IC50 (binding) | = 112 nM | Affinity for dopamine receptor D2 binding sites by its ability to displace [3H]-spiperone from rat striatum. | ChEMBL. | 7707315 |
IC50 (binding) | = 112 nM | Affinity for dopamine receptor D2 binding sites by its ability to displace [3H]-spiperone from rat striatum. | ChEMBL. | 7707315 |
Ratio (binding) | = 56 | Ratio of IC50 value against dopamine receptor D2 to that of 5-hydroxytryptamine 3 receptor. | ChEMBL. | 7707315 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.